2023;46(Suppl):S418
Yohena T, Yoshino I, Takenaka T, Kameyama T, Ohba T, Kuniyoshi Y, et al
The major cardiovascular safety trials The SUSTAIN-6 trial enrolled 3,297 patients with type 2 diabetes and high cardiovascular risk, following them for two years on semaglutide 0.5 mg or 1.0 mg weekly versus placebo
Follow-up check-ins at weeks four and eight allow us to assess your response and adjust if needed
Phytother Res 28(9):13491358 Khonche A, Biglarian O, Panahi Y, Valizadegan G, Soflaei S, Ghamarchehreh M, Majeed M, Sahebkar A (2016) Adjunctive therapy with curcumin for peptic ulcer: a randomized controlled trial
deficiencies in iron, B12, or thyroid function can amplify cold sensitivity independent of semaglutide